News

Ladies and gentleman, baseball season is back. "A lot going on here today, an exciting day here at the ballpark," said Jake Starr with The Reading Fightin Phils Media Relations. At First Energy ...
The phase 1b trial is investigating the ADC and Keytruda – with or without chemo – in both previously-untreated and pretreated patients with advanced NSCLC who don’t have genetic mutations ...
Jointly Bayer and Orion Corporation-developed NUBEQA (Darolutamide) + Androgen Deprivation Therapy (ADT) in combination with docetaxel is to be the first prostate cancer treatment to be made ...